Used as a key intermediate in the synthesis of non-nucleoside reverse transcriptase inhibitors (NNRTIs), particularly in antiviral medications targeting HIV. Its structure enables effective binding to the reverse transcriptase enzyme, making it valuable in pharmaceutical development. Also employed in the preparation of bioactive molecules and heterocyclic compounds for drug discovery research. Its ester and hydroxyl functional groups allow for easy modification, facilitating the creation of derivative compounds with potential therapeutic activity.